The Drugs Rules, 1945 were amended by notification G.S.R. 927(E) dated 29 December 2025, which omitted the word 'Syrup' from Schedule K. Cough syrups lose the exemption that let them be sold without a retail licence in villages of under 1,000 people. MoHFW announced the change on 16 June 2026.
In such villages, cough syrups may now be sold and dispensed only through licensed pharmacies under the Drugs and Cosmetics Act, 1940.
The ministry's stated aim is tighter regulatory oversight of syrup formulations. The change follows diethylene glycol (DEG)-contaminated syrup deaths, including the 2025 Coldrif tragedy in Chhindwara, Madhya Pradesh.
Regulates the import, manufacture, distribution and sale of drugs and cosmetics. Section 5 creates the Drugs Technical Advisory Board and Section 7 the Drugs Consultative Committee
Exemptions for listed drug classes. This amendment narrows them for cough syrups
Good Manufacturing Practice norms notified on 28 December 2023 and aligned with WHO-GMP. The compliance deadline for MSME units (turnover below Rs 250 crore) was extended to 31 December 2025
National drug regulator: approves new drugs and clinical trials, sets standards, controls imported drugs, and coordinates state drug controllers
Highest technical advisory body under the Act; advises the Centre and the states
WHO alert on four Maiden Pharmaceuticals syrups linked to the deaths of about 70 children in The Gambia
Marion Biotech syrups (Dok-1 Max, Ambronol) linked to child deaths in Uzbekistan; WHO found them substandard
Revised Schedule M (GMP) notified
At least 23 children die in Chhindwara, MP, after taking Coldrif (Sresan Pharmaceuticals, Tamil Nadu), which carried DEG nearly 500 times the limit
DCGI orders testing of every batch of excipients and APIs before use
G.S.R. 927(E) withdraws the Schedule K syrup exemption
Syrups use propylene glycol or glycerine as solvents. Cheap industrial-grade supplies can be adulterated with DEG, which causes acute kidney failure and is deadliest in children. Batch testing of excipients is the main safeguard.
GS Paper 2 > Health > Regulatory Bodies
Current Affairs > Health; Static GK > Acts
Drugs Rules schedule exempting listed drug classes from certain licensing provisions
Drugs Rules schedule prescribing Good Manufacturing Practices; revised in December 2023
An inactive ingredient, such as a solvent or sweetener, that carries the active drug